Our platform will enable the commercialization of previously untapped molecules—unleashing a new molecular economy.
These five components are the backbone:
We are transforming the status quo so more medicine can be grown, shared, and produced using molecular pharming. If we can help decentralize drug discovery and production globally for healing and human health, can you imagine the benefits?
The steep prices of biologic drugs are alarming to many patients, physicians, and researchers. It's a bitter pill to swallow for the world when two billion people don't have access to medicine.
In every corner of the world, we envision a Zea Lighthouse that provides a center of excellence for growing therapeutics in plants.
For universities, researchers, scientists, and corporations, they get a platform that:
For big pharma, they gets access to a novel drug discovery platform that:
Years of plant biologic research has been sitting in labs, unable to become commercialized because of the unsurmountable challenges around both production and precision when using plants as bioreactors.
By using the Zea Lighthouse platform, we can deliver minimal variation and high replicability to a targeted expression molecule.
"Using plants to discover, validate, and grow medicines is a decades-old idea that's finally becoming a reality." --Charles Legg, COO of Zea
Molecular Pharming represents an unprecedented opportunity to manufacture affordable modern medicines and make these available at a global scale. The area of greatest potential is in the prevention of infectious diseases, particular in underdeveloped countries where access to medicines and vaccines has historically been limited.